Literature DB >> 159146

T cell-mediated immune responses of lupus-prone BXSB mice and other murine strains.

W D Creighton, R M Zinkernagel, F J Dixon.   

Abstract

Cellular-mediated immunity in the newly described BXSB strain of mice, which is prone to autoimmune disease, has been compared with that of two other strains, C57Bl/6 and 129/J. Quantificaiton of cytotoxic T cell responses to alloantigens and viruses (lymphocytic choriomeningitis and vaccinia virus) showed no difference in the kinetics of appearance and relative activity of cytotoxic T cells per spleen between the young and old BXSB and the control mice. The T cell-dependent primary footpad swelling after local injection with lymphocytic choriomeningitis virus was within the same range for all strains tested with respect to kinetics, but the size was greater by two-fold in C57Bl/6 mice. The susceptibility to systemic infection and subsequent induction of lymphocytes immune to Listeria monocytogenes were about equivalent in all strains. However, clearance of Listeria by the reticuloendothelial system and early non-immune bactericidal activity of the young and old BXSB were significantly lower than in the control strains. The results indicate that the cellular-mediated immunity (CMI) of BXSB mice compared favourably with that of other strains and that there is no apparent differences between CMI of BXSB mice before the onset of disease and during the course of disease. The role of the reduced reticuloendothelial function of BXSB mice in their autoimmune disease or in their high susceptibility to infection remains to be determined.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 159146      PMCID: PMC1537809     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  40 in total

1.  Age and genetic influence on immunity in NZB and autoimmune-resistant mice.

Authors:  G Fernandes; E J Yunis; R A Good
Journal:  Clin Immunol Immunopathol       Date:  1976-11

2.  Reaction of mouse strains to skin test for ectromelia using an allied virus as inoculum.

Authors:  D Owen; A Hill; S Argent
Journal:  Nature       Date:  1975-04-17       Impact factor: 49.962

3.  Age-associated decline in the in vitro development of cytotoxic lymphocytes in NZB mice.

Authors:  T Hirano; A A Nordin
Journal:  J Immunol       Date:  1976-10       Impact factor: 5.422

4.  Resistance and susceptibility of mice to bacterial infection: genetics of listeriosis.

Authors:  C Cheers; I F McKenzie
Journal:  Infect Immun       Date:  1978-03       Impact factor: 3.441

5.  Target cell-dependent T cell-mediated lysis of vaccinia virus-infected cells.

Authors:  U Koszinowski; R Thomssen
Journal:  Eur J Immunol       Date:  1975-04       Impact factor: 5.532

6.  Systemic lupus erythematosus. Contrasts and comparisons.

Authors:  J L Decker; A D Steinberg; M E Gershwin; W E Seaman; J H Klippel; P H Plotz; S A Paget
Journal:  Ann Intern Med       Date:  1975-03       Impact factor: 25.391

7.  Comparison of T cell-mediated immune responsiveness of NZB, (NZB x &NZW)F1 hybrid and other murine strains.

Authors:  R M Zinkernagel; F J Dixon
Journal:  Clin Exp Immunol       Date:  1977-07       Impact factor: 4.330

8.  Macrophage clearance function and immune complex disease in New Zealand Black/White F1 hybrid mice.

Authors:  A G Morgan; M W Steward
Journal:  Clin Exp Immunol       Date:  1976-10       Impact factor: 4.330

9.  H-2 compatibility requirement for virus-specific T-cell-mediated cytolysis. The H-2K structure involved is coded by a single cistron defined by H-2Kb mutant mice.

Authors:  R M Zinkernagel
Journal:  J Exp Med       Date:  1976-02-01       Impact factor: 14.307

10.  Cellular resistance to infection.

Authors:  G B MACKANESS
Journal:  J Exp Med       Date:  1962-09-01       Impact factor: 14.307

View more
  1 in total

1.  Analysis of T cell function in autoimmune murine strains. Defects in production and responsiveness to interleukin 2.

Authors:  A Altman; A N Theofilopoulos; R Weiner; D H Katz; F J Dixon
Journal:  J Exp Med       Date:  1981-09-01       Impact factor: 14.307

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.